MCM
ABBV icon

MAI Capital Management’s AbbVie ABBV Stock Holding History

MAI Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-2,000
Closed -$184K – 472
2018
Q4 		$184K Hold
2,000
– – 0.01% 414
2018
Q3 		$189K Hold
2,000
– – 0.01% 453
2018
Q2 		$185K Hold
2,000
– – 0.01% 453
2018
Q1 		$189K Buy
+2,000
New +$220K 0.01% 434

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

MAI Capital Management's ABBV Position: Q1 2026 in Review

MAI Capital Management increased its AbbVie (ABBV) stake by 0.31% in Q1 2026, buying an estimated $392K and bringing the position to 577,833 shares worth $126M. The position accounts for 0.71% of the portfolio, ranked #29.

MAI Capital Management first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $132M in Q4 2025. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • MAI Capital Management held 577,833 shares of AbbVie worth $126M as of Q1 2026.
  • MAI Capital Management bought 1,766 AbbVie shares in Q1 2026, an estimated $392K.
  • AbbVie made up 0.71% of MAI Capital Management's portfolio in Q1 2026, its #29 holding.
  • MAI Capital Management first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
  • MAI Capital Management's AbbVie position peaked at $132M in Q4 2025.
  • 4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on MAI Capital Management's 13F filing for Q1 2026, filed 15 May 2026.